Nitrendipine
525
relevant articles (76 outcomes,
123 trials/studies)
found for this Bio-Agent
Description:
A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
Also Known As:
1A Brand of Nitrendipine; AbZ Brand of Nitrendipine; Aliud Brand of Nitrendipine; Almirall Brand of Nitrendipine; Alpharma Brand of Nitrendipine; Apogepha Brand of Nitrendipine; Azupharma Brand of Nitrendipine; BC Brand of Nitrendipine; Balminil; Basics Brand of Nitrendipine; Bay e 5009; Bayer Brand of Nitrendipine; Bayotensin; Baypresol; Baypress; Bayvit Brand of Nitrendipine; Biomed Brand of Nitrendipine; Dexcel Brand of Nitrendipine; Docpharm Brand of Nitrendipine; Elan Brand of Nitrendipine; Elfar Brand of Nitrendipine; Gericin; Heumann Brand of Nitrendipine; Hexal Brand of Nitrendipine; Jenapharm Brand of Nitrendipine; Juta Brand of Nitrendipine; Jutapress; KSK Pharma Brand of Nitrendipine; Lichtenstein Brand of Nitrendipine; Lindopharm Brand of Nitrendipine; Merck dura Brand of Nitrendipine; Nidrel; Niprina; Nitre AbZ; Nitre-Puren; Nitregamma; Nitren 1A Pharma; Nitren Lich; Nitren acis; Nitrend KSK; Nitrendepat; Nitrendi Biochemie; Nitrendidoc; Nitrendimerck; Nitrendipin AL; Nitrendipin Apogepha; Nitrendipin Atid; Nitrendipin Basics; Nitrendipin Heumann; Nitrendipin Jenapharm; Nitrendipin Lindo; Nitrendipin Stada; Nitrendipin beta; Nitrendipin-ratiopharm; Nitrendipino Bayvit; Nitrendipino Ratiopharm; Nitrensal; Nitrepress; Prevision y Salud Brand of Nitrendipine; Q-Pharm Brand of Nitrendipine; Schwarz Brand of Nitrendipine; Seid Brand of Nitrendipine; Stadapharm Brand of Nitrendipine; TAD Brand of Nitrendipine; Tensogradal; Trendinol; Vastensium; Wörwag Brand of Nitrendipine; acis Brand of Nitrendipine; betapharm Brand of Nitrendipine; corax Brand of Nitrendipine; ct-Arzneimittel Brand of Nitrendipine; nitrendipin von ct; nitrendipin-corax; ratiopharm Brand of Nitrendipine; 1A Pharma, Nitren; AL, Nitrendipin; AbZ, Nitre; Apogepha, Nitrendipin; Atid, Nitrendipin; Basics, Nitrendipin; Bayvit, Nitrendipino; Biochemie, Nitrendi; Heumann, Nitrendipin; Jenapharm, Nitrendipin; KSK, Nitrend; Lich, Nitren; Lindo, Nitrendipin; Nitre Puren; NitrePuren; Nitrendipin ratiopharm; Nitrendipine 1A Brand; Nitrendipine AbZ Brand; Nitrendipine Aliud Brand; Nitrendipine Almirall Brand; Nitrendipine Alpharma Brand; Nitrendipine Apogepha Brand; Nitrendipine Azupharma Brand; Nitrendipine BC Brand; Nitrendipine Basics Brand
Relationship Network
Bio-Agent Context: Research Results
Experts
| 1. | Delgadillo, J:
2 articles
(04/2003 - 12/2001)
|
| 2. | Terán, M:
2 articles
(04/2003 - 12/2001)
|
| 3. | Lin, C L:
2 articles
(03/2001 - 01/2001)
|
| 4. | Zhang, Z X:
2 articles
(03/2001 - 01/2001)
|
| 5. | Xu, Y J:
2 articles
(03/2001 - 01/2001)
|
| 6. | Jung, F:
1 article
(01/2008)
|
| 7. | Park, J-W:
1 article
(01/2008)
|
| 8. | Leithäuser, B:
1 article
(01/2008)
|
| 9. | Laeis, Petra:
1 article
(10/2007)
|
| 10. | Mallion, Jean-Michel:
1 article
(10/2007)
|
Related Diseases
| 1. | Hypertension (High Blood Pressure)
|
| 2. | Ischemia
|
| 3. | Syndrome
|
| 4. | Stroke (Strokes)
|
| 5. | Dementia (Dementias)
05/01/2003
- " In addition, nitrendipine-based blood pressure-lowering therapy decreased the incidence of dementia" 09/01/1999
- " In conclusion, in subjects over the age of 60 years with isolated systolic HT, antihypertensive treatment initiated with nitrendipine can reduce the incidence of dementia." 08/01/1999
- " CONCLUSION: In older people with isolated systolic hypertension, antihypertensive treatment started with nitrendipine may reduce the incidence of dementia" 07/29/2000
- " A preventive effect of current antihypertensive treatment is likely, according to preliminary evidence (particularly with regard to the use of the calcium antagonist nitrendipine), but the hopeful perspective of protection against dementias through antihypertensive treatment remains to be confirmed by further prospective comparative trials." 01/01/2003
- " In particular, the results of the Syst-Eur study, showing that a calcium inhibitor, nitrendipine, could reduce not only the incidence of stroke but also that of dementia, should be confirmed."
Order ALL the reference details at left...
|
|
Related Drugs and Biologics
Related Therapies and Procedures